Three measurements can appear on one prescription
Milligrams describe an amount of medicine. Milliliters describe a volume of liquid. Syringe units are device markings. You need the prescription, concentration and correct syringe to understand how those pieces fit together for your own supply.
FDA has reported compounded-semaglutide errors involving confusion between these measurements. The warning describes patients receiving many times the intended dose and calls for counseling and an appropriate syringe. A number of units without its matching concentration and device is incomplete information.
A new vial can require a new explanation
When a pharmacy, formulation or concentration changes, an old syringe-marking instruction may no longer apply. Keep the new label and written instructions together. Ask the pharmacist to reconcile any mismatch between the prescription, portal message and vial label before an injection.
Request a demonstration with the supplied syringe and your actual prescribed amount. This article does not provide a conversion calculator or a dosing table because a general example can be mistaken for an individualized instruction.
Do not derive a prescription from the total vial amount
A vial’s total quantity tells you what it contains, not the dose your clinician intended or a reason to change escalation. Ask how many prescribed doses the pharmacy expects the supply to provide and whether multiple containers should be opened at different times.
A longer package can contain medication that must be discarded after opening. FDA’s current guidance on compounded GLP-1 multidose vials recommends a 28-day discard period after first use. Do not extend that period because a larger invoice or leftover liquid makes waste frustrating.
Sources: FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss | FDA
Separate a measurement question from a dose-change request
The pharmacist can explain how the dispensed prescription is measured. A change in the clinical dose requires the prescriber’s direction. Keep those discussions connected so that the instructions you receive describe the same current plan.
A dose from another patient, a community chart or a previous provider can refer to a different concentration and clinical history. If the new instructions remain unclear, contact the care team before proceeding rather than testing an estimate.
Sources: FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products | FDA · FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss | FDA
Know where to turn when an error may have happened
If you think you administered the wrong amount, obtain prompt medical guidance and provide the vial label, concentration, amount drawn and timing. In the United States, Poison Help at 1-800-222-1222 connects you with a poison center for immediate advice. Contact your prescriber and pharmacist as well. Do not attempt to compensate with a later dose or wait for a general billing support ticket to be answered.
FDA’s warning includes serious symptoms and hospitalization in some reports. Your provider should supply a clear plan for urgent concerns. Seek urgent medical care for severe symptoms, and let the prescriber and pharmacist know what happened so that the prescription instructions can be reviewed.
Sources: FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products | FDA · HRSA Poison Help: first steps in a poisoning emergency